Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Waystar HoldingWAY -1.64%14 3-Year EBITDA Growth Rate is 8.90% as of Jun. 2026, which is 3% above its 10-year median of 8.60. GuruFocus rates WAY with a GF Score™ of 14/100. The stock has 3 warning signs investors should review. Among 524 Healthcare Providers & Services companies, Waystar Holding ranks worse than 51.91% on this metric.
During the past 12 months, Waystar Holding's average EBITDA Per Share Growth Rate was 6.60% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 8.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 5 years, the highest 3-Year average EBITDA Per Share Growth Rate of Waystar Holding was 8.90% per year. The lowest was 8.30% per year. And the median was 8.60% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Waystar Holding 3-Year EBITDA Growth Rate Related Terms
WAY vs DOCS, PRVA, HNGE: 3-Year EBITDA Growth Rate Comparison
For the Health Information Services subindustry, Waystar Holding's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Waystar Holding 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Waystar Holding's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Waystar Holding's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 8.90% mean?
Waystar Holding (WAY) has a 3-Year EBITDA Growth Rate of 8.90% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Waystar Holding and its competitors. This is near median its historical median of 8.60. Over the past decade, Waystar Holding's 3-Year EBITDA Growth Rate has ranged from 8.30 to 8.90. According to the industry distribution chart, Waystar Holding ranks #272 out of 524 companies in the Healthcare Providers & Services industry, placing it in the top 51.9%.
Is Waystar Holding's 3-Year EBITDA Growth Rate too high?
Waystar Holding's current 3-Year EBITDA Growth Rate of 8.90% is near median its 10-year median of 8.60. Over the past 10 years, this metric has ranged from a low of 8.30 to a high of 8.90. The Healthcare Providers & Services industry median 3-Year EBITDA Growth Rate is 10.20. Waystar Holding's value of 8.90% is 12.7% below this industry median. Based on the distribution chart, Waystar Holding ranks #272 out of 524 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Waystar Holding has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Waystar Holding's 3-Year EBITDA Growth Rate compare to DOCS and PRVA?
According to the Healthcare Providers & Services industry distribution chart, Waystar Holding ranks #272 out of 524 companies for 3-Year EBITDA Growth Rate. This places Waystar Holding in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 10.20. Waystar Holding's value of 8.90% is 12.7% below this benchmark. Historically, Waystar Holding's own 3-Year EBITDA Growth Rate has ranged from 8.30 to 8.90 over the past decade. While the company's 10-year median is 8.60 vs. the industry median of 10.20, Waystar Holding has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 10.20, based on 524 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Waystar Holding's current 3-Year EBITDA Growth Rate of 8.90% is 12.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Waystar Holding and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 10.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Waystar Holding's current 3-Year EBITDA Growth Rate is 8.90%, which is near median its own 10-year median of 8.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Waystar Holding stock overvalued right now?
Waystar Holding (WAY) has a current 3-Year EBITDA Growth Rate of 8.90%. The current 3-Year EBITDA Growth Rate is 8.90%, which is near median its 10-year median of 8.60 and 12.7% below the Healthcare Providers & Services industry median of 10.20. Waystar Holding's overall GF Score™ is 14/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Waystar Holding (WAY), the current 3-Year EBITDA Growth Rate is 8.90% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Waystar Holding Corp is a provider of mission-critical cloud technology to healthcare organizations. Its enterprise-grade platform transforms the complex and disparate processes comprising healthcare payments received by healthcare providers from payers and patients, from pre-service engagement through post-service remittance and reconciliation. its platform enhances data integrity, eliminates manual tasks, and improves claim and billing accuracy, which results in transparency, reduced labor costs, and faster, more accurate reimbursement and cash flow. The market for solutions extends throughout the United States and includes Puerto Rico and other USA Territories.
14GF Score
Get the complete analysis for WAY
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAY has been successfully added to your 
